Journal of Basic and Clinical Health Sciences

The Journal of Basic and Clinical Health Sciences (JBACHS) (ISSN 2458-8938) (E-ISSN 2564-7288) is an international open access periodical, officially owned by the Dokuz Eylül University, Institute of Health Sciences. The Journal is published three issues per annum in English. It is a multidisciplinary journal, aimed at attracting contributions from basic and clinical health sciencies as well as community medicine and public health. It has a special focus on research on translational medicine. Translational and/or interdisciplinary manuscripts linking basic science with the clinical and population practice will be given priority in the journal.

The JBACHS publishes peer-reviewed original articles, editorials, reviews, pictorial essays, technical notes, letters to the editor and case reports related to all fields of basic and clinical health sciences. The JBACHS also focuses on providing physicians with continuing education in basic and clinical sciences to enhance clinical decisions and improve health care quality internationally. The target audience of the journal includes academicians, researchers, specialists and primary care physicians working in the fields of basic and clinical health sciences.

Please carefully follow the guidelines below.

Any manuscripts not meeting these guidelines will be returned to the corresponding author for correction, which may cause significant delays in the peer review process.

The Journal is published in English. Therefore, only articles written in English are taken into the review process.

The manuscripts should be prepared in accordance with ICMJE-Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals (updated in December 2016 - http://www.icmje. org/icmje-recommendations.pdf). Authors are required to prepare manuscripts in accordance with CONSORT guidelines for randomized controlled clinical studies, STROBE guidelines for Observational original research studies, STARD guidelines for studies on diagnostic accuracy, PRISMA guidelines for systematic reviews and meta-analysis, ARRIVE guidelines for experimental animal studies, TREND guidelines for non-randomized public behaviour and CARE checklist for case series.

Manuscripts can only be submitted through the journal’s online manuscript submission and evaluation system, available at https://dergipark.org.tr/tr/journal/3471/submission/step/manuscript/new. Manuscripts submitted via any other medium will not be evaluated.

Title, type of the manuscript, full names of the authors, their ORCID numbers and addresses at the time of the research was carried out should be submitted during on-line submission.

Manuscripts submitted to the journal will first go through a technical evaluation process where the editorial office will ensure that the manuscript is prepared and submitted in accordance with the journal’s guidelines. Submissions that don’t conform to the journal’s guidelines will be returned to the submitting author with technical correction requests. The manuscripts sent to the journal are first approved by the technical editor during the pre-check. If it is found appropriate after the pre-check, it is sent to 2 or 3 reviewers (blind review) through the field editor. If both of the reviewers approve the publication of the article, the article is included in the publication list for the appropriate issue. If one reviewer expresses a positive opinion and another a negative opinion, it is sent to the third reviewer and it is decided whether the article will be published or not, according to the opinion of the 3rd reviewer. If a correction is requested by the reviewer(s), the correction period for the authors is 10–15 days. If the time expires, the article will be rejected. The editor has the authority to extend the period.

Authors are required to submit the documents below, during the initial submission. Required forms are available on the journal’s website.
1) Copyright Transfer Form,
2) Author Contributions Form,
3) Similarity report (The similarity rate should be less than %20),
4) Approval of Ethics Committee (For all research articles and case reports, including in vitro and in silico studies),
5) ICMJE Potential Conflict of Interest Disclosure Form (should be filled in by all contributing authors)

Title page: A separate title page should be submitted with all submissions and this page should include;
The full title of the manuscript as well as a short title (running head) of no more than 50 characters, Name(s), affiliations of the author(s), Grant information and detailed information on the other sources of support, the Name, address, telephone (including the mobile phone number) and fax numbers and an e-mail address of the corresponding author, acknowledgement of the individuals who contributed to the preparation of the manuscript not fulfilling the authorship criteria.
The first letters of authors’ names should begin with capital letter, and surnames should be written with capital letters. If there is more than one author; corresponding author should be indicated. The name, surname, work address, telephone, fax and e-mail address of the corresponding author should be submitted at the related page. The e-mail address should be selected as the most permanent one.
The title of the article should be written in lower letters in the title page. Acknowledgement, author(s) contribution(s), funding, ethical approval should be indicated at the end of the title page as a separate subtitle. Writing information about ‘Author Contribution, Conflict of Interest, Funding and Ethical statement’ is obligatory.

Approval of Ethics Committee: According to the Journal of Basic and Clinical Health Sciences rules, ethical approval is obligatory for all research articles and case reports (including in vitro and in silico studies).
*Articles at any stage, are subject to the journal's retraction process if ethical concerns arise.

Abstract: An abstract should be submitted with all submissions except for letters to the editor. The abstract of Original Articles should be structured with subheadings (Background and Purpose, Methods, Results and Conclusion). The abstract must not be longer than 200 words and must clearly emphasise the objective of the study, experimental procedure(s), key results, and conclusions. The abstract must not contain mathematical formulae and an abbreviation.  The abstract must not contain any reference citations.

Keywords: Each submission must be accompanied by a minimum of three and a maximum of six keywords for subject indexing at the end of the abstract. The keywords should be listed in full without abbreviations.

Manuscript Types
1) Original Articles: This is the most important type of article since it provides new information based on original research. If the information is accurate and important, and the conclusions are substantiated by the data provided, the paper serves to advance health sciences.
The main text should be structured with Introduction, Materials and Methods, Results and Discussion subheadings.
Statistical analysis to support conclusions is usually necessary. Statistical analyses must be conducted in accordance with the international statistical reporting standards (Altman DG, Gore SM, Gardner MJ, Pocock SJ. Statistical guidelines for contributors to medical journals. Br Med J 1983: 7; 1489-93). Information on statistical analyses should be provided with a separate subheading under the Materials and Methods section and statistical software that was used during the process must certainly be specified. Data must be expressed as mean±standard deviation when parametric tests are used to compare continuous variables. Data must be expressed as median (minimum-maximum) and percentiles (25th and 75th percentiles) when non-parametric tests are used. In advanced and complicated statistical analyses, relative risk (RR), odds ratio (OR) and hazard ratio (HR) must be supported by confidence intervals (CI) and p values.

Description: Clinical trial, Meta-analysis, Interventional study, Cohort study, Epidemiologic assessment, Survey with high response rate, Cost-effectiveness analysis, Decision analysis, Study of screening and diagnostic tests, Observational study
Requirements: 3000 words, ≤5 tables and/or figures, Structured abstract, ≤50 references

2) Review Articles: Review articles are scientific analysis of recent developments on a specific topic as reported in the literature. Articles prepared by authors who have an extensive knowledge on a particular field and whose scientific background has been translated into high volume of publication and high citation potential are taken under review. No new information is described, and no opinions or personal experiences are expressed. Reviews should only include the highlights on a topic. The authors can structure the main text of review articles according to their preferences.

*Review articles will be accepted upon request of the editorial board. The journal does not accept unsolicited review articles for consideration.

Description: Up-to-date review on a topic of general common interest from the perspective of internationally recognized experts in these disciplines. The focus should be an update on current understanding of the physiology of the disease or condition, diagnostic consideration, and treatment. These reviews should address a specific question or issue that is relevant for clinical practice.
Requirements: 2000-3500 words, ≤5 tables and/or figures, Unstructured abstract, ≤75 references

3) Case Report: These manuscripts are short reports of original studies or evaluations or unique, first-time reports of clinical case series.
Description: Short reports of original studies or evaluations or unique, first-time reports of clinical case series.
Requirements: 1000-1200 words (not including abstract, tables, figures, acknowledgments, references, and online-only material), ≤5 tables and/or figures, Structured abstract, ≤15 references

4) Letter to the Editor and Reply: Letters to the Editor and Replies should offer objective and constructive criticism of published content. Letters may also discuss matters of general interest to physicians and academicians and may include images.
Description: Letters discussing a recent article in this journal should be submitted within 4 weeks of the article's publication online.
Requirements: 400 words, ≤3 authors≤5 references (1 of which should be to the recent article)

Main text
Names of the authors and their affiliations should not be stated in the file containing main text. Text should be prepared with MS Word document. All text should be written with Arial font type at 10 font size and 1.15 spaced on A4 sized paper with 2.5 cm right margin and 2.5 cm other margins. There should be no indentation at the beginning of the paragraph. Header and/or footer should not be inserted in the text except that the pages should be numbered with Arabic numerals. Title should be written in sentence case; that is, first letter of the initial word should be written in capital letter and rest of the title should be typed with lower case letters except proper nouns and abbreviations.

Tables
Tables should be included in the main document, presented after the reference list and they should be numbered consecutively in the order they are referred to within the main text. A descriptive title must be placed above the tables. Abbreviations used in the tables should be defined below the tables by footnotes (even if they are defined within the main text). Tables should be created using the “insert table” command of the word processing software and they should be arranged clearly to provide an easy reading. Data presented in the tables should not be a repetition of the data presented within the main text but should be supporting the main text.

Figures and Figure Legends
Figures, graphics and photographs should be submitted as separate files (in TIFF or JPEG format) through the submission system. The files should not be embedded in a Word document or the main document. When there are figure subunits, the subunits should not be merged to form a single image. Each subunit should be submitted separately through the submission system. Images should not be labelled (a, b, c, etc.) to indicate figure subunits. Thick and thin arrows, arrowheads, stars, asterisks and similar marks can be used on the images to support figure legends. Like the rest of the submission, the figures should be blind as well. Any information within the images that may indicate an individual or institution should be blinded. The minimum resolution of each submitted figure should be 300 DPI. To prevent delays in the evaluation process all submitted figures should be clear in resolution and large in size (minimum dimensions 100x100 mm). Figure legends should be listed at the end of the main document.

All acronyms and abbreviations used in the manuscript should be defined at first use, both in the abstract and the main text. The abbreviation should be provided in parenthesis following the definition.

When a drug, product, hardware, or software mentioned within the main text product information, including the name of the product, producer of the product, city of the company and the country of the company should be provided in parenthesis in the following format: “Discovery St PET/CT scanner (General Electric, Milwaukee, WI, USA)”
All references, tables and figures should be referred to within the main text and they should be numbered consecutively in the order they are referred to within the main text.

Limitations, drawbacks and shortcomings of original articles should be mentioned in the “Discussion” section before the conclusion paragraph.

Gene Names, Symbols, and Accession Numbers
Authors describing genes or related structures in a manuscript should include the names and official symbols provided by the US National Center for Biotechnology Information (NCBI) or the HUGO Gene Nomenclature Committee.

References
While citing publications, preference should be given to the latest, most up to date publications. Authors are responsible for the accuracy of references. Journal titles should be abbreviated in accordance with the journal abbreviations in Index Medicus/ Medline/PubMed (for journal abbreviations consult the List of Journals indexed for MEDLINE, published annually by NLM). When there are 6 or fewer authors, all authors should be listed. If there are 7 or more authors the first 3 authors should be listed followed by “et al”. In the main text of the manuscript, references should be cited using Arabic numbers in parentheses. The reference styles for different types of publications are presented in the following examples:

Journal article: Thomas EL, Hamilton G, Patel N, et al. Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut 2005;54(1):122-127.
Book Section: Sherry S. Detection of thrombi. In: Strauss HE, Pitt B, James AE, editors. Cardiovascular Medicine. St Louis: Mosby; 1974.p.273-285.
Books with Single Author: Cohn PF. Silent myocardial ischemia and infarction. 3rd ed. New York: Marcel Dekker; 1993.
Editor(s) as author: Norman IJ, Redfern SJ, editors. Mental health care for elderly people. New York: Churchill Livingstone; 1996.
Conference Proceedings: Bengisson S. Sothemin BG. Enforcement of data protection, privacy and security in medical informatics. In: Lun KC, Degoulet P, Piemme TE, Rienhoff O, editors. MEDINFO 92. Proceedings of the 7th World Congress on Medical Informatics; 1992 Sept 6-10; Geneva, Switzerland. Amsterdam: North-Holland; 1992.p.1561-1565.
Scientific or Technical Report: Smith P. Golladay K. Payment for durable medical equipment billed during skilled nursing facility stays. Final report. Dallas (TX) Dept. of Health and Human Services (US). Office of Evaluation and Inspections: 1994 Oct. Report No: HHSIGOE 169200860.
Thesis: Kaplan SI. Post-hospital home health care: the elderly access and utilization (dissertation). St. Louis (MO): Washington Univ. 1995.
Epub ahead of print Articles: Aksu HU, Ertürk M, Gül M, Uslu N. Successful treatment of a patient with pulmonary embolism and biatrial thrombus. Anadolu Kardiyol Derg 2012 Dec 26. doi: 10.5152/akd.2013.062. [Epub ahead of print]
Manuscripts published in electronic format: Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis (serial online) 1995 Jan-Mar (cited 1996 June 5): 1(1): (24 screens). Available from: URL: https://www.cdc.gov/ncidodlElD/cid.htm.
Web page: Journal of Basic and Clinical Health Sciences [Internet]. Author Guidelines. [Accessed date: 30 December 2022]. Available from: https://dergipark.org.tr/en/pub/jbachs/writing-rules

‘Manuscripts accepted for publication, not published yet’ cannot be cited as a reference.

REVISIONS
When submitting a revised version of a paper, the author must submit a detailed “Response to reviewers” that states point by point how each issue raised by the reviewers has been covered and where it can be found (each reviewer’s comment followed by the author’s reply and line numbers where the changes have been made) as well as an annotated copy of the main document. Revised manuscripts must be submitted within 30 days from the date of the decision letter. If the revised version of the manuscript is not submitted within the allocated time, the revision option may be cancelled. If the submitting author(s) believe that additional time is required, they should request this extension before the initial 30-day period is over.

PROOFS AND DOI NUMBER
Accepted manuscripts are copy-edited for grammar, punctuation, and format. Once the publication process of a manuscript is completed its PDF proof is prepared for the checks. A PDF proof of the accepted manuscript is sent to the corresponding author and their publication approval is requested within 2 days of their receipt of the proof. Manuscripts accepted for publication are provided with a DOI number immediately after proof check.

*Please get in direct contact with the Editorial Office if you have any questions or comments regarding the peer-review process.

** JBACHS is published three times a year in January, May and September upon the request of Institute of Health Sciences.

Author Contribution:  https://dergipark.org.tr/tr/download/journal-file/26028
Conflict of Interest: https://dergipark.org.tr/tr/download/journal-file/25807
Copyright Transfer Form: https://dergipark.org.tr/tr/download/journal-file/26029
Main Text Template: https://dergipark.org.tr/en/download/journal-file/24590 
Title Page Template: https://dergipark.org.tr/en/download/journal-file/24591 
Case Report Template: https://dergipark.org.tr/en/download/journal-file/24662 

An approval of research protocols by Ethics Committee in accordance with international agreements (World Medical Association Declaration of Helsinki “Ethical Principles for Medical Research Involving Human Subjects”, amended in October 2013, www.wma.net) is required for experimental, clinical and drug studies and some case reports. If required, ethics committee reports or an equivalent official document may be requested from the authors. For manuscripts concerning experimental research on humans, a statement should be included that shows informed consent of patients and volunteers was obtained following a detailed explanation of the procedures that they may undergo. For studies carried out on animals, the measures taken to prevent pain and suffering of the animals should be stated clearly. Information on patient consent, name of the ethics committee and the ethics committee approval number should also be stated in the materials and methods section of the manuscript. It is the authors’ responsibility to carefully protect the patients’ anonymity. For photographs that may reveal the identity of the patients, signed releases of the patient or of their legal representative should be enclosed.

Ethical principles and publication Policy
Ethics committee approval must be obtained for research conducted in all disciplines that requires ethics committee approval, and the “committee name, date, and issue number” of this approval should be stated and documented in the method section of the article and on the last page before the references section.

Journal policy
Manuscripts submitted to Journal of Basic and Clinical Health Sciences will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in their fields in order to ensure an unbiased evaluation process. No fee is charged for the manuscript submitted to the journal.
Due to the variability that may occur in the duration of the evaluation processes, number-based articles are not accepted. The manuscripts accepted as a result of the review processes are put in the queue for the first issue to be published. In the journal, the pre-control and reviewer assignment periods take place on an average of 7–10 days. After the review process starts, the reviewers have a 15-day invitation period and a 30-day evaluation period. Since this process may vary according to the reviewers, it is not possible to give precise information about whether the work you will submit will be able to reach the numbers whose article acceptance is ongoing.

The correction period given to the authors is 15 days, and the works that are not requested for corrections within this period will be rejected. An extension period can be added for this period if the editors are consulted. Authors can withdraw their work only during the pre-check period. In other cases, if peer-review processes have been initiated, studies can only be returned by the editors. Our journal has adopted the Open Access Policy and is served only in Dergipark. The Journal of Basic and Clinical Health Sciences requires each submission to be accompanied by a Copyright Agreement. By signing this form, authors retain the copyright of their work and agree that the article, if accepted for publication by the Journal of Basic and Clinical Health Sciences will be licensed.

Ethical guidelines for journal editors
The editor should reject the article in the case of ethical violations.
Journal editors should give unbiased consideration to each manuscript submitted for publication. They should judge each on its merits, without regard to race, religion, nationality, sex, seniority, or institutional affiliation of the author(s).
Journal editors must keep the peer-review process confidential. They must not share information about a manuscript with anyone outside of the peer-review process.
Journal editors may reject a submitted manuscript without formal peer review if they consider it to be inappropriate for the journal and outside its scope.
Journal editors should make all reasonable effort to process submissions on time.
Journal editors should delegate the peer review of any original self-authored research article to a member of the editorial or advisory board as appropriate.
Any data or analysis presented in a submitted manuscript should not be used in a journal editor’s own research without the consent of the author.
The editor has full responsibility to reject, accept or request changes to the articles submitted to the journal.

Ethical guidelines for authors
Authors must declare that the manuscript they submit is original and has not previously been published elsewhere.
Authors must declare that their manuscript is not currently being considered by another journal.
All authors named in the study must have contributed to the experimental design and execution of the study, as well as the data analysis and interpretation.
Authors should provide access to the data sets used in the study, if deemed necessary.
Authors must notify the editorial board if they discover an important error in their published article.
For studies that require ethics committee approval, authors should submit it to the journal.If "Ethics Committee Approval" is required for the research, information regarding the approval of the Ethics Committee (name of the ethics committee, number and date of the approval document) should be stated in the article.

Within the framework of ethical rules, studies that require Ethics Committee Permission for evaluation in the journal are as follows:
- All types of qualitative or quantitative research that requires data collection from participants via surveys, interviews, focus group work, observation, experiments, or interview techniques.
- The use of humans and animals (including material and data) for experimental or other scientific purposes,
- Clinical studies on humans,
- Studies on animals,
- Retrospective studies in accordance with the personal data protection law.

Ethical guidelines for peer reviewers
All peer reviewers must follow these ethical guidelines for Journal of Basic and Clinical Health Sciences journal articles in review:

Reviewers must give unbiased consideration to each manuscript submitted. They should judge each on its merits, without regard to race, religion, nationality, sex, seniority, or institutional affiliation of the author(s).
Reviewers must declare any conflict of interest before agreeing to review a manuscript. This includes any relationship with the author that may bias their review.
Reviewers must keep the peer review process confidential. They must not share information or correspondence about a manuscript with anyone outside of the peer review process.
Reviewers should provide a constructive, comprehensive, evidenced, and appropriately substantial peer review report.
Reviewers must avoid making statements in their report which might be construed as impugning any person’s reputation.
Reviewers should make all reasonable effort to submit their report and recommendation on time. They should inform the editor if this is not possible.
Reviewers should call to the journal editor’s attention any significant similarity between the manuscript under consideration and any published paper or submitted manuscripts of which they are aware.

Editorial and blind peer review processes
Editors are obliged to implement the "Blind Peer-Review and Evaluation Process" policies included in the journal's publication policies. In this context, the editors ensure that the fair, impartial, and timely evaluation process of each work is completed.

Quality assurance
The editor is responsible for publishing every article published in the journal in accordance with journal publication policies and international standards.

Protection of personal data
Editors are obliged to ensure the protection of personal data regarding the subjects or images included in the evaluated studies. Unless the explicit consent of the individuals used in the studies is documented, they are responsible for refusing the study. In addition, editors are responsible for protecting the individual data of authors, reviewers, and readers.

Protection of intellectual property rights
Editors must protect the intellectual property rights of all published articles and defend the rights of the journal and the author(s) in the event of a possible violation. In addition, the editors are obliged to take the necessary measures so that the contents of all published articles do not violate the intellectual property rights of other publications.

Political and commercial concerns
The journal's owner, publisher, and no other political or commercial factors affect the editors' independent decision-making.

Conflicts of interest
The Editors consider potential conflicts of interest between the author(s), reviewers, and other editors and ensure that the studies are published in an independent and impartial manner.

There are no submission fees, publication fees or page charges for this journal.